Donald Trump’s second administration has advanced an avalanche of policy action and political pronouncements that have jolted ...
Hosted on MSN12m
Iterum Therapeutics Highlights FDA Approval and Market PotentialIterum Therapeutics (($ITRM)) has held its Q4 earnings call. Read on for the main highlights of the call. During Iterum Therapeutics’ latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback